FIELD: chemistry.SUBSTANCE: invention relates to novel nitrogen-containing heteroaryl derivatives of formula,where Aand Aare independently selected from a group consisting of CH and N, under the condition that Aand Aare simultaneously N； Ris C-C-alkyl, C-C-alkoxy, C-C-alkoxy-C-C-alkyl or cycloalkyl； Rand Rare independently a hydrogen atom or C-C-alkyl； Ris a 6-member heteroaryl containing 2 heteroatoms selected from N； Y is a 5-member heteroaryl selected from a group consisting of:where said heteroaryl is optionally substituted with one substitute selected from a group consisting of C-C-alkyl, which is optionally substituted with 1-3 substitutes selected from a group consisting of aryl, cycloalkyl, a 6-member heterocyclyl 2 heteroatoms selected from O and N, C-C-alkoxy, hydroxyl, halogen atom, amino group, optionally substituted with one or two C-C-alkyl substitutes, cyano and a 5-member heteroaryl containing 2 heteroatoms selected from N, optionally substituted with 1-3 substitutes selected from C-C-alkyl, COO-C-C-alkyl, cycloalkyl and a 6-member heterocyclyl containing 1 heteroatom, selected from O, N, optionally substituted with 1-3 substitutes selected from C-C-alkyl； and Ris phenyl or a 6- or 10-member heteroaryl containing one or two nitrogen atoms, where said phenyl and said heteroaryl are optionally substituted with 1-3 substitutes selected from a group consisting of a halogen atom, C-C-alkoxy, or pharmaceutically acceptable salts thereof.EFFECT: compounds inhibit PDE10A (phosphodiesterase 10A) and can be used as medicinal agents.14 cl, 66 ex, 1 tblИзобретение относится к новым азотсодержащим гетероарильным производным формулы (I),гдеАи Анезависимо выбраны из группы, состоящей из СН и N, при условии, что Аи Аодновременно не представляют собой N； Rпредставляет собой C-С-алкил, C-С-алкокси, C-С-алкокси-C-С-алкил или циклоалкил； Rи Rнезависимо представляют собой атом водорода или C-С-алкил； Rпредставляет собой 6-членный гетероарил, содержащий 2 гетероатома, выб
